Prosperity Consulting Group’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.49M | Buy |
13,867
+4
| +0% | +$430 | 0.11% | 172 |
|
2025
Q1 | $1.4M | Buy |
13,863
+86
| +0.6% | +$8.68K | 0.11% | 182 |
|
2024
Q4 | $1.23M | Buy |
13,777
+775
| +6% | +$69.2K | 0.09% | 201 |
|
2024
Q3 | $1.09M | Buy |
13,002
+3,810
| +41% | +$319K | 0.09% | 215 |
|
2024
Q2 | $708K | Buy |
9,192
+1,354
| +17% | +$104K | 0.1% | 148 |
|
2024
Q1 | $537K | Buy |
7,838
+1,242
| +19% | +$85.1K | 0.07% | 194 |
|
2023
Q4 | $381K | Buy |
6,596
+1,302
| +25% | +$75.3K | 0.13% | 134 |
|
2023
Q3 | $280K | Buy |
+5,294
| New | +$280K | 0.13% | 117 |
|